// App-Quantinova.ai

TCT CONNECT-267 : BIOVITESSE—Multicenter Prospective First-In-Man Study of a New Polymer-Free Drug-Coated Stent With Ultrathin Struts: Clinical Study Outcome

Researchers

Presenter

  • Lorenz Raber

Principal Investigators

  • Jonas Haener

  • Ron Waksman

  • Thomas Luscher

  • Marco Moccetti

  • Stefan Stortecky

  • Stephane Fournier

  • Hector Garcia-Garcia

  • Patrick Siegrist

Medical Centers

  • Universitats Spital, Zurich, Switzerland

  • Cardiovascular Department, Bern University Hospital, Bern, Switzerland

  • Cardiocentro Ticino, Lugano, Switzerland

  • Medstar Washington Hosp Ctr, Washington, DC

  • Royal Brompton and Harefield Hospital Trust, London, United Kingdom

  • Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • Universitatsspital Bern, Bern, Switzerland

  • Washington Hospital Center, Chevy Chase, Maryland, USA

Locations

  • Switzerland

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved